D. N. Louis, A. Perry, and G. Reifenberger, The 2016 World Health Organization classification of tumors of the central nervous system: a summary, Acta Neuropathol, vol.131, issue.6, pp.803-820, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01479018

T. Hennika, G. Hu, and N. G. Olaciregui, Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models, PLoS One, vol.12, issue.1, p.169485, 2017.

C. S. Grasso, Y. Tang, and N. Truffaux, Functionally defined therapeutic targets in diffuse intrinsic pontine glioma, Nat Med, vol.21, issue.6, pp.555-559, 2015.

, Clinical Trials Website, 2019.

J. Montero, K. A. Sarosiek, and J. D. Deangelo, Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy, Cell, vol.160, issue.5, pp.977-989, 2015.

J. Deng, N. Carlson, K. Takeyama, P. Dal-cin, M. Shipp et al., BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents, Cancer Cell, vol.12, issue.2, pp.171-185, 2007.

N. Truffaux, C. Philippe, and J. Paulsson, Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma, Neuro Oncol, vol.17, issue.7, pp.953-964, 2015.

D. Reczek, M. Berryman, and A. Bretscher, Identification of EBP50: A PDZcontaining phosphoprotein that associates with members of the ezrinradixin-moesin family, J Cell Biol, vol.139, issue.1, pp.169-179, 1997.

J. Vaquero, N. Ho-bouldoires, T. H. Clapéron, A. Fouassier, and L. , Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance, Oncogene, vol.36, issue.22, pp.3067-3079, 2017.

T. Shiratsuchi, M. Futamura, K. Oda, H. Nishimori, Y. Nakamura et al., Cloning and characterization of BAI-associated protein 1: a PDZ domaincontaining protein that interacts with BAI1, Biochem Biophys Res Commun, vol.247, issue.3, pp.597-604, 1998.

G. Scita, S. Confalonieri, P. Lappalainen, and S. Suetsugu, IRSp53: crossing the road of membrane and actin dynamics in the formation of membrane protrusions, Trends Cell Biol, vol.18, issue.2, pp.52-60, 2008.

S. Ahmed, W. I. Goh, and W. Bu, I-BAR domains, IRSp53 and filopodium formation, Semin Cell Dev Biol, vol.21, issue.4, pp.350-356, 2010.

C. Saponaro, S. Sergio, and A. Coluccia, ?-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy, Oncogene, vol.37, issue.24, pp.3301-3316, 2018.

P. Salmon, J. Oberholzer, T. Occhiodoro, P. Morel, J. Lou et al., Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes, Mol Ther, vol.2, issue.4, pp.404-414, 2000.

E. Richard, M. Mendez, and F. Mazurier, Gene therapy of a mouse model of protoporphyria with a self-inactivating erythroid-specific lentiviral vector without preselection, Mol Ther, vol.4, issue.4, pp.331-338, 2001.

T. Dull, R. Zufferey, and M. Kelly, A third-generation lentivirus vector with a conditional packaging system, J Virol, vol.72, issue.11, pp.8463-8471, 1998.

P. Mélard, Y. Idrissi, and L. Andrique, Molecular alterations and tumor suppressive function of the DUSP22 (dual specificity phosphatase 22) gene in peripheral T-cell lymphoma subtypes, Oncotarget, vol.7, issue.42, pp.68734-68748, 2016.

E. Henriet, A. Hammoud, A. Dupuy, and J. W. , Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk, Hepatology, vol.66, issue.6, pp.2016-2028, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01550711

M. Hagedorn, S. Javerzat, and D. Gilges, Accessing key steps of human tumor progression in vivo by using an avian embryo model, Proc Natl Acad Sci, vol.102, issue.5, pp.1643-1648, 2005.

T. H. Millard, J. Dawson, and L. M. Machesky, Characterisation of IRTKS, a novel IRSp53/MIM family actin regulator with distinct filament bundling properties, J Cell Sci, vol.120, pp.1663-1672, 2007.

W. I. Goh, K. B. Lim, and T. Sudhaharan, mDia1 and WAVE2 proteins interact directly with IRSp53 in filopodia and are involved in filopodium formation, J Biol Chem, vol.287, issue.7, pp.4702-4714, 2012.

Y. Funato, T. Terabayashi, N. Suenaga, M. Seiki, T. Takenawa et al., IRSp53/Eps8 complex is important for positive regulation of Rac and cancer cell motility/invasiveness, Cancer Res, vol.64, issue.15, pp.5237-5244, 2004.

L. Y. Ballester, Z. Wang, and S. Shandilya, Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas, Am J Surg Pathol, vol.37, issue.9, pp.1357-1364, 2013.

P. J. Mohler, S. M. Kreda, R. C. Boucher, M. Sudol, M. J. Stutts et al., Yes-associated protein 65 localizes p62(c-Yes) to the apical compartment of airway epithelia by association with EBP50, J Cell Biol, vol.147, issue.4, pp.879-890, 1999.

B. A. Orr, H. Bai, Y. Odia, D. Jain, R. A. Anders et al., Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth, J Neuropathol Exp Neurol, vol.70, issue.7, pp.568-577, 2011.

K. L. Kislin, W. S. Mcdonough, J. M. Eschbacher, B. A. Armstrong, and M. E. Berens, NHERF-1: modulator of glioblastoma cell migration and invasion, Neoplasia, vol.11, issue.4, pp.377-387, 2009.

T. M. Schroeder, A. K. Nair, R. Staggs, A. F. Lamblin, and J. J. Westendorf, Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors, BMC Genomics, vol.8, p.362, 2007.

A. Dudakovic, E. T. Camilleri, and E. A. Lewallen, Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adiposederived mesenchymal stromal cells, J Cell Physiol, vol.230, issue.1, pp.52-62, 2015.

A. Dudakovic, J. M. Evans, and Y. Li, Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation, J Biol Chem, vol.288, issue.40, pp.28783-28791, 2013.

D. Garbett, C. Sauvanet, R. Viswanatha, and A. Bretscher, The tails of apical scaffolding proteins EBP50 and E3KARP regulate their localization and dynamics, Mol Biol Cell, vol.24, issue.21, pp.3381-3392, 2013.

D. Grillo-bosch, D. Choquet, and M. Sainlos, Inhibition of PDZ domain-mediated interactions, Drug Discov Today Technol, vol.10, issue.4, pp.531-540, 2013.

Y. Hayashi, J. R. Molina, S. R. Hamilton, and M. M. Georgescu, NHERF1/EBP50 is a new marker in colorectal cancer, Neoplasia, vol.12, issue.12, pp.1013-1022, 2010.

Z. Zhou, R. Singh, and M. M. Souweidane, Convection-enhanced delivery for diffuse intrinsic pontine glioma treatment, Curr Neuropharmacol, vol.15, issue.1, pp.116-128, 2017.